Newly Acquired Infection With Multidrug-Resistant HIV-1 in a Patient Adherent to Preexposure Prophylaxis

被引：55
|
作者：
Markowitz, Martin [1 ]
Grossman, Howard [2 ]
Anderson, Peter L. [3 ]
Grant, Robert [4 ]
Gandhi, Monica [4 ]
Horng, Howard [4 ]
Mohri, Hiroshi [1 ]
机构：
[1] Rockefeller Univ, Aaron Diamond AIDS Res Ctr, 1230 York Ave, New York, NY 10021 USA
[2] Cleveland Clin Florida, Weston, FL 33331 USA
[3] Univ Colorado, Anschutz Med Campus, Aurora, CO USA
[4] Univ Calif San Francisco, Gladstone Inst, San Francisco, CA 94143 USA
来源：
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES | 2017年 / 76卷 / 04期
关键词：
ANTIRETROVIRAL THERAPY; TRANSMISSION; RISK; MEN;
D O I：
10.1097/QAI.0000000000001534
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：E104 / E106
页数：3
相关论文
共 50 条
  • [41] Southern African guidelines on the safe use of pre-exposure prophylaxis in persons at risk of acquiring HIV-1 infection
    Bekker, Linda-Gail
    Rebe, Kevin
    Venter, Francois
    Maartens, Gary
    Moorhouse, Michelle
    Conradie, Francesca
    Wallis, Carole
    Black, Vivian
    Harley, Beth
    Eakles, Robyn
    SOUTHERN AFRICAN JOURNAL OF HIV MEDICINE, 2016, 17 (01)
  • [42] A Novel Tricyclic Ligand-Containing Nonpeptidic HIV-1 Protease Inhibitor, GRL-0739, Effectively Inhibits the Replication of Multidrug-Resistant HIV-1 Variants and Has a Desirable Central Nervous System Penetration Property In Vitro
    Amano, Masayuki
    Tojo, Yasushi
    Salcedo-Gomez, Pedro Miguel
    Parham, Garth L.
    Nyalapatla, Prasanth R.
    Das, Debananda
    Ghosh, Arun K.
    Mitsuya, Hiroaki
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2015, 59 (05) : 2625 - 2635
  • [43] Intentions to Use Preexposure Prophylaxis Among Current Phase 2B Preventive HIV-1 Vaccine Efficacy Trial Participants
    Fuchs, Jonathan D.
    Sobieszczyk, Magdalena E.
    Madenwald, Tamra
    Grove, Doug
    Karuna, Shelly T.
    Andrasik, Michele
    Sherwat, Adam
    Broder, Gail
    Mayer, Kenneth
    Koblin, Beryl
    Hammer, Scott
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2013, 63 (03) : 259 - 262
  • [44] Low Prevalence of Transmitted Drug Resistance in Patients Newly Diagnosed with HIV-1 Infection in Sweden 2003-2010
    Karlsson, Annika
    Bjoerkman, Per
    Bratt, Goeran
    Ekvall, Hakan
    Gisslen, Magnus
    Soennerborg, Anders
    Mild, Mattias
    Albert, Jan
    PLOS ONE, 2012, 7 (03):
  • [45] 1-Year Incidence of Tuberculosis Infection and Disease Among Household Contacts of Rifampin- and Multidrug-Resistant Tuberculosis
    Krishnan, Sonya
    Wu, Xingye
    Kim, Soyeon
    McIntire, Katie
    Naini, Linda
    Hughes, Michael D.
    Dawson, Rodney
    Mave, Vidya
    Gaikwad, Sanjay
    Sanchez, Jorge
    Mendoza-Ticona, Alberto
    Gonzales, Pedro
    Comins, Kyla
    Shenje, Justin
    Fontain, Sandy Nerette
    Omozoarhe, Ayotunde
    Mohapi, Lerato
    Lalloo, Umesh G.
    Ferreira, Ana Cristina Garcia
    Mugah, Christopher
    Harrington, Mark
    Shah, N. Sarita
    Hesseling, Anneke C.
    Churchyard, Gavin
    Swindells, Susan
    Gupta, Amita
    CLINICAL INFECTIOUS DISEASES, 2023, 77 (06) : 892 - 900
  • [46] Minority Quasispecies of Drug-Resistant HIV-1 That Lead to Early Therapy Failure in Treatment-Naive and -Adherent Patients
    Metzner, Karin J.
    Giulieri, Stefano G.
    Knoepfel, Stefanie A.
    Rauch, Pia
    Burgisser, Philippe
    Yerly, Sabine
    Guenthard, Huldrych F.
    Cavassini, Matthias
    CLINICAL INFECTIOUS DISEASES, 2009, 48 (02) : 239 - 247
  • [47] CD4:CD8 ratio in children with perinatally acquired HIV-1 infection
    Seers, T.
    Vassallo, P.
    Pollock, K.
    Thornhill, J. P.
    Fidler, S.
    Foster, C.
    HIV MEDICINE, 2018, 19 (09) : 668 - 672
  • [48] Preexposure Prophylaxis with Albumin-Conjugated C34 Peptide HIV-1 Fusion Inhibitor in SCID-hu Thy/Liv Mice
    Stoddart, Cheryl A.
    Nault, Genevieve
    Galkina, Sofiya A.
    Bousquet-Gagnon, Nathalie
    Bridon, Dominique
    Quraishi, Omar
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (04) : 2162 - 2165
  • [49] Acquisition of wild-type HIV-1 infection in a patient on pre-exposure prophylaxis with high intracellular concentrations of tenofovir diphosphate: a case report
    Hoornenborg, Elske
    Prins, Maria
    Achterbergh, Roel C. A.
    Woittiez, Lycke R.
    Cornelissen, Marion
    Jurriaans, Suzanne
    Kootstra, Neeltje A.
    Anderson, Peter L.
    Reiss, Peter
    de Vries, Henry J. C.
    Prins, Jan M.
    de Bree, Godelieve J.
    LANCET HIV, 2017, 4 (11): : E522 - E528
  • [50] Impact of a targeted isolation strategy at intensive-care-unit-admission on intensive-care-unit-acquired infection related to multidrug-resistant bacteria: a prospective uncontrolled before-after study
    Ledoux, G.
    Six, S.
    Lawson, R.
    Labreuche, J.
    Blazejewski, C.
    Wallet, F.
    Duhamel, A.
    Nseir, S.
    CLINICAL MICROBIOLOGY AND INFECTION, 2016, 22 (10) : 888.e11 - 888.e18
12345